We analyzed the predictive value of CD161 in the anti-PD-1 cohort of urothelial carcinoma (Imvigor 210), the anti-PD-1 cohort of NSCLC(GSE136961), and GBMcohort, respectively. This evidence concerns the gene KLRB1 and non-small cell lung carcinoma.